Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 40Rectal Neoplasms 21Colorectal Neoplasms 20Colonic Neoplasms 19Glioblastoma 13Pancreatic Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Stomach Neoplasms 11Gliosarcoma 11Central Nervous System Neoplasms 11Esophageal Neoplasms 9Prostatic Neoplasms 8Lung Neoplasms 8Head and Neck Neoplasms 8Uterine Cervical Neoplasms 7Carcinoma, Intraductal, Noninfiltrating 7Adenocarcinoma Of Esophagus 7Squamous Cell Carcinoma of Head and Neck 6Sarcoma 6Ovarian Neoplasms 6Neoplasm Metastasis 6Carcinoma, Ovarian Epithelial 6Breast Neoplasms, Male 6Melanoma 5Esophageal Squamous Cell Carcinoma 5Breast Carcinoma In Situ 5Salivary Gland Neoplasms 4Nasopharyngeal Carcinoma 4Lymphoma 4Fallopian Tube Neoplasms 4

Interventions

Gemcitabine 3folfirinox 2Cisplatin 2paricalcitol 1nimotuzumab 1Taxes 1Granulocyte-Macrophage Colony-Stimulating Factor 1Colony-Stimulating Factors 1Chemotherapy, Adjuvant 1Chemoradiotherapy, Adjuvant 1Albumin-Bound Paclitaxel 1Adjuvants, Immunologic 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Resectable Pancreatic Cancer × Chemotherapy, Adjuvant × Clear all
NCT04737551 2021-02-04

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

Shanghai Zhongshan Hospital

Unknown
400 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡